Drug Search Results
More Filters [+]

Methylcellulose

Alternative Names: methylcellulose, citrucel
Latest Update: 2024-08-15
Latest Update Note: Clinical Trial Update

Product Description

Methylester of cellulose. Methylcellulose is used as an emulsifying and suspending agent in cosmetics, pharmaceutics and the chemical industry. It is used therapeutically as a bulk laxative.

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Ophthalmic

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Canada | Chile | Colombia | Dominican Republic | Egypt | India | Ireland | Jordan | Korea | Malaysia | New Zealand | Pakistan | Philippines | South Africa | Spain | Taiwan | Thailand | United Arab Emirates | United Kingdom | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: ORA
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Methylcellulose

Countries in Clinic: India

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Acanthamoeba Keratitis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

UCSF-IRB-17-23895

P2

Active, not recruiting

Acanthamoeba Keratitis

2024-12-31

Recent News Events